AIDS Deaths Fall by 19% in United States

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 8
Volume 6
Issue 8

WASHINGTON--The number of deaths from AIDS has fallen 19%, from 37,900 in the first nine months of 1995 to 30,700 for the same time period in 1996, the Centers for Disease Control and Prevention (CDC) has announced. And, for the first time, the number of AIDS-related deaths has dropped among women, albeit by only 7%, as compared to 22% among men.

WASHINGTON--The number of deaths from AIDS has fallen 19%, from 37,900in the first nine months of 1995 to 30,700 for the same time period in1996, the Centers for Disease Control and Prevention (CDC) has announced.And, for the first time, the number of AIDS-related deaths has droppedamong women, albeit by only 7%, as compared to 22% among men.

The heartening news appears to be due primarily to new drug therapiesdeveloped to combat the virus and to treat AIDS-related complications,as well as improved access to medical care.

The greatest decrease was among white patients (28%), compared with16% for Hispanics and 10% for blacks.

Recent Videos
9 Experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
An advanced computation linguistics model that can detect pancreatic cysts can help patients prevent pancreatic tumors from forming.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
Related Content